Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000224946 is a predicted pseudogene with sequence similarity to part of the ubiquitin-specific peptidase 22 (USP22) gene. Pseudogenes are nonfunctional segments of DNA that resemble functional genes but are generally incapable of encoding functional proteins due to disabling mutations such as frameshifts or premature stop codons. The specific pseudogene in question does not have evidence of producing a functional protein or acting as a classic therapeutic target (such as a receptor, enzyme, transporter, etc.). Some pseudogenes can be transcriptionally active and may have regulatory roles at the RNA level, such as producing antisense transcripts that modulate their ancestral gene or other targets, but such roles are sequence- and context-dependent and not established for every pseudogene. As such, ENSG00000224946 is not considered a valid therapeutic or biomarker target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to ubiquitin-specific peptidase 22 (ENSG00000224946).